MONIMUS CAPITAL MANAGEMENT, LP
Position in VKTX — Viking Therapeutics, Inc.
CIK 1848831
WOODBRIDGE, NJ
Position in VKTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,594,243
+$386,697 QoQ
Shares Held
66,502
-2.0% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#99
of 436 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MONIMUS CAPITAL MANAGEMENT, LP holds $20,968,537 across 10 Biotechnology names. VKTX ranks #4 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
20,845 | $3,903,851 | |
| 2 | PRTA |
Prothena Corp Public Ltd Co
|
329,052 | $3,221,419 | |
| 3 | ABVX |
Abivax S.A.
|
21,644 | $2,884,279 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
This page
|
66,502 | $2,594,243 | |
| 5 | QURE |
uniQure N.V.
|
51,066 | $2,352,099 | |
| 6 | QTTB |
Q32 Bio Inc.
|
132,036 | $1,682,138 | |
| 7 | ASMB |
Assembly Biosciences, Inc.
|
47,580 | $1,307,498 | |
| 8 | PEPG |
PepGen Inc.
|
587,688 | $1,057,838 |
All Filings in VKTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,594,243 | 66,502 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,207,546 | 67,841 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $402,529 | 11,442 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $787,795 | 29,977 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $623,598 | 23,532 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $546,828 | 22,643 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $845,281 | 21,006 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||